Modern Dental Group (3600) Announces Nine-Month 2025 Results with 9.2% Revenue Growth

Bulletin Express
2025/11/27

Modern Dental Group (3600) reported that total revenue for the nine months ended 30 September 2025 reached approximately HK$2,752.4 million, marking a 9.2% increase from the HK$2,521.6 million recorded in the same period of 2024. This performance took place despite international trade uncertainties and generally softer demand for dental procedures.

Modern Dental Group attributed the results to multi-dimensional strategies, operational efficiency gains, and the ongoing adoption of digitalization initiatives in the dental industry. By leveraging production facilities in Thailand, Vietnam, and Mainland China, the company sought to enhance competitiveness and successfully expand its market share.

In terms of regional performance, Europe’s revenue increased to HK$1,365.5 million (+2.8% in currency terms, +10.7% in original currency). North America’s revenue decreased to HK$534.4 million, impacted by weaker cosmetic treatment demand, although offshore-made products in the region recorded growth. Greater China’s revenue amounted to HK$455.0 million, constrained by volume-based procurement policies and intense price competition. Australia’s revenue rose to HK$215.0 million (-3.4% in currency terms, +12.8% in original currency). The “Others” category reached HK$182.5 million, primarily driven by the acquisition of Hexa Ceram in January 2025, which contributed HK$137.9 million.

Overall sales volumes grew 29.5% to about 2,115,000 cases. Excluding the additional 456,000 cases from Hexa Ceram, sales volumes increased by approximately 1.6% year on year. Digital solution cases rose to 698,000, reflecting a 24.4% jump from the previous comparable period. The average selling price was HK$1,227 per case, representing a 14.9% decline from HK$1,442, mainly due to the addition of Hexa Ceram. Excluding Hexa Ceram, the average selling price was HK$1,474 per case, roughly in line with the year before.

According to Modern Dental Group, these figures are based on preliminary management accounts and have not been audited. The unaudited operational data should be reviewed alongside the most recent annual and interim reports. The foundation of the company’s strategies remains focused on reinforcing international market presence and maintaining a prudent approach amid evolving industry and economic conditions.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10